Efficacy and safety of liposomal amphotericin B for deep mycosis in patients with connective tissue disease.

MLA

Kotani, Takuya, et al. “Efficacy and Safety of Liposomal Amphotericin B for Deep Mycosis in Patients with Connective Tissue Disease.” Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.), vol. 19, no. 4, Aug. 2013, pp. 691–97. EBSCOhost, https://doi.org/10.1007/s10156-012-0545-x.

APA

Kotani, T., Takeuchi, T., Makino, S., Hata, K., Yoshida, S., Nagai, K., Wakura, D., Isoda, K., & Hanafusa, T. (2013). Efficacy and safety of liposomal amphotericin B for deep mycosis in patients with connective tissue disease. Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.), 19(4), 691–697. https://doi.org/10.1007/s10156-012-0545-x

Chicago

Kotani, Takuya, Tohru Takeuchi, Shigeki Makino, Kenichiro Hata, Shuzo Yoshida, Koji Nagai, Daisuke Wakura, Kentaro Isoda, and Toshiaki Hanafusa. 2013. “Efficacy and Safety of Liposomal Amphotericin B for Deep Mycosis in Patients with Connective Tissue Disease.” Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.) 19 (4): 691–97. doi:10.1007/s10156-012-0545-x.